WELL Health Technologies (WELL.TO) reported last Friday that a billing investigation involving CircleMedical has been resolved with the North District of California for a US$3.3 million payment and "no admission of wrong doing", notes Stifel Canada.
Analyst Justin Keywood, who is maintaining a buy rating and $8.25 price target on the shares of Well Health, says the resolution could preempt a sale for CircleMedical, which is estimated to be worth ~C$30 million to C$45 million in proceeds (WELL holds 71%). While a relatively small asset, a divestiture could act as a catalyst in highlighting WELL's pure-play pursuit and Canadian healthcare consolidation model, Keywood adds.
WELL has publicly stated it intends to divest some or all of its U.S. assets, including CRH Medical, WISP and Circle Medical.
CircleMedical is a primary care platform and tech-enabled medical practice, providing virtual care across 26 U.S. states and in-person care through physical facilities at 27 locations.
Price: $4.57, Change: $+0.02, Percent Change: +0.44%